Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 1,265 | 1,283 | 1,173 | 1,240 | 902 |
| Cost of Goods | 771 | 817 | 883 | 916 | 881 |
| Gross Profit | 493 | 466 | 290 | 324 | 21 |
| Operating Expenses | 3,019 | 3,292 | 2,969 | 2,945 | 3,526 |
| Operating Income | -1,754 | -2,009 | -1,796 | -1,705 | -2,624 |
| Other Income | 76 | 78 | 73 | 227 | 88 |
| Pre-tax Income | -1,678 | -1,931 | -1,723 | -1,478 | -2,537 |
| Net Income Continuous | -1,678 | -1,938 | -1,723 | -1,478 | -2,537 |
| Net Income | $-1,678 | $-1,938 | $-1,723 | $-1,478 | $-2,537 |
| EPS Basic Total Ops | -2.71 | 291.95 | -3.58 | -3.71 | -304.80 |
| EPS Basic Continuous Ops | -2.71 | 292.04 | -3.58 | -3.71 | -304.89 |
| EPS Diluted Total Ops | -2.71 | 291.95 | -3.58 | -3.71 | -304.80 |
| EPS Diluted Continuous Ops | -2.71 | 292.04 | -3.58 | -3.71 | -304.89 |
| EPS Diluted Before Non-Recurring Items | -2.71 | -3.80 | -3.60 | N/A | N/A |
| EBITDA(a) | $-1,700 | $-1,954 | $-1,741 | $-1,650 | $-2,570 |